141 related articles for article (PubMed ID: 29755082)
1. [Pulmonary Pleomorphic Carcinoma Relapsed after Surgery Surviving Long-term by Chemotherapy and Nivolumab].
Kawamata O; Murata T; Uda M
Kyobu Geka; 2018 May; 71(5):329-333. PubMed ID: 29755082
[TBL] [Abstract][Full Text] [Related]
2. Five-year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non-small-cell lung cancer.
Kanda S; Ohe Y; Goto Y; Horinouchi H; Fujiwara Y; Nokihara H; Yamamoto N; Yamamoto T; Tamura T
Cancer Sci; 2020 Jun; 111(6):1933-1942. PubMed ID: 32277531
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study.
Kanda S; Goto K; Shiraishi H; Kubo E; Tanaka A; Utsumi H; Sunami K; Kitazono S; Mizugaki H; Horinouchi H; Fujiwara Y; Nokihara H; Yamamoto N; Hozumi H; Tamura T
Ann Oncol; 2016 Dec; 27(12):2242-2250. PubMed ID: 27765756
[TBL] [Abstract][Full Text] [Related]
4. Long-term complete response in a patient with disseminated pulmonary pleomorphic carcinoma induced by cisplatin and gemcitabine.
Tamiya A; Asami K; Shimizu S; Matsumura A; Isa S; Okishio K; Kitaichi M; Atagi S; Takada M; Kawaguchi T; Kubo A
Intern Med; 2014; 53(22):2625-8. PubMed ID: 25400187
[TBL] [Abstract][Full Text] [Related]
5. Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Rizvi NA; Hellmann MD; Brahmer JR; Juergens RA; Borghaei H; Gettinger S; Chow LQ; Gerber DE; Laurie SA; Goldman JW; Shepherd FA; Chen AC; Shen Y; Nathan FE; Harbison CT; Antonia S
J Clin Oncol; 2016 Sep; 34(25):2969-79. PubMed ID: 27354481
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of efficacy and safety of adding bevacizumab to chemotherapy as first- and second-line therapy in advanced non-small-cell lung cancer (NSCLC).
Quan R; Huang J; Chen N; Fang W; Hu Z; Zhan J; Zhou T; Zhang L; Zhang H
Tumour Biol; 2016 Aug; 37(8):11479-84. PubMed ID: 27012553
[TBL] [Abstract][Full Text] [Related]
7. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG).
Kotsakis A; Kentepozidis N; Emmanouilidis Ch; Polyzos A; Agelidou A; Vaslamatzis M; Chandrinos V; Agelaki S; Vamvakas L; Kalbakis K; Katsaounis P; Stoltidis D; Nintos G; Hatzidaki D; Vetsika EK; Mavroudis D; Georgoulias V
Lung Cancer; 2015 Apr; 88(1):57-62. PubMed ID: 25662596
[TBL] [Abstract][Full Text] [Related]
8. An Open-Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non-Small Cell Lung Cancer.
Patil PD; Shapiro M; Hashemi Sadraei N; Pennell NA
Oncologist; 2019 Apr; 24(4):457-e126. PubMed ID: 30602615
[TBL] [Abstract][Full Text] [Related]
9. [A case of advanced large cell lung carcinoma for whom fourth-line chemotherapy of cisplatin and gemcitabine proved effective for the first time].
Tambo Y; Kasahara K; Fujimura M; Tamori S; Araya T; Sone T; Nakao S
Gan To Kagaku Ryoho; 2007 Feb; 34(2):217-9. PubMed ID: 17301530
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Nieto Y; Tu SM; Bassett R; Jones RB; Gulbis AM; Tannir N; Kingham A; Ledesma C; Margolin K; Holmberg L; Champlin R; Pagliaro L
Ann Oncol; 2015 Oct; 26(10):2125-32. PubMed ID: 26199392
[TBL] [Abstract][Full Text] [Related]
11. [Refractory non-small-cell lung cancer responding to combination chemotherapy with docetaxel, gemcitabine and cisplatin].
Satouchi M; Kotani Y; Kadou T; Endo M; Ohbayashi K; Takada Y
Gan To Kagaku Ryoho; 2001 Jan; 28(1):105-9. PubMed ID: 11201378
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: a substudy of the Avastin in Lung trial.
Mok TS; Hsia TC; Tsai CM; Tsang K; Chang GC; Chang JW; Sirisinha T; Sriuranpong V; Thongprasert S; Chua DT; Moore N; Manegold C
Asia Pac J Clin Oncol; 2011 Jun; 7 Suppl 2():4-12. PubMed ID: 21585703
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.
Edelman MJ; Clark JI; Chansky K; Albain K; Bhoopalam N; Weiss GR; Giguere JK; Kelly K; Crowley J; Gandara DR
Clin Cancer Res; 2004 Aug; 10(15):5022-6. PubMed ID: 15297403
[TBL] [Abstract][Full Text] [Related]
14. A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).
Fukumoto SI; Oizumi S; Harada M; Sukoh N; Nakano K; Fuke S; Sakakibara-Konishi J; Takamura K; Ito K; Fujita Y; Nishigaki Y; Harada T; Akie K; Kinoshita I; Amano T; Isobe H; Dosaka-Akita H; Nishimura M;
Cancer Chemother Pharmacol; 2020 Jul; 86(1):117-127. PubMed ID: 32564128
[TBL] [Abstract][Full Text] [Related]
15. [Carboplatin].
Watanabe H
Nihon Rinsho; 2002 May; 60 Suppl 5():366-9. PubMed ID: 12101690
[No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
Detterbeck FC; Socinski MA; Gralla RJ; Edelman MJ; Jahan TM; Loesch DM; Limentani SA; Govindan R; Zaman MB; Ye Z; Monberg MJ; Obasaju CK
J Thorac Oncol; 2008 Jan; 3(1):37-45. PubMed ID: 18166839
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.
Lv C; Ma Y; Wu N; Yan S; Zheng Q; Sun Y; Li S; Fang J; Yang Y
World J Surg Oncol; 2013 Mar; 11():76. PubMed ID: 23517534
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer.
Karapanagiotou EM; Charpidou A; Tzannou I; Dilana K; Kotteas E; Tourkantonis I; Kosmas E; Provata A; Syrigos K
Med Oncol; 2008; 25(3):303-8. PubMed ID: 18204976
[TBL] [Abstract][Full Text] [Related]
19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
20. [Docetaxel].
Takigawa N
Nihon Rinsho; 2002 May; 60 Suppl 5():349-52. PubMed ID: 12101686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
